{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:56Z","timestamp":1786119296150,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1097\/mca.0b013e32832c4538","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T06:35:57Z","timestamp":1242887757000},"page":"288-294","source":"Crossref","is-referenced-by-count":6,"title":["Intensive LOwering of BlOod pressure and low-density lipoprotein ChOlesterol with statin theraPy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease"],"prefix":"10.1097","volume":"20","author":[{"given":"Yosuke","family":"Takamiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Ichiro","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tanigawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keijiro","family":"Saku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210204","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1001\/jama.287.24.3215","article-title":"Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial","volume":"287","author":"Serruys","year":"2002","journal-title":"JAMA"},{"key":"R2-6-20210204","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5551\/jat.14.45","article-title":"Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese","volume":"14","author":"Teramoto","year":"2007","journal-title":"J Atheroscler Thromb"},{"key":"R3-6-20210204","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N Engl J Med"},{"key":"R4-6-20210204","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa042000","article-title":"Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease","volume":"352","author":"Nissen","year":"2005","journal-title":"N Engl J Med"},{"key":"R5-6-20210204","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2169\/internalmedicine.45.1757","article-title":"Lower level of low-density lipoprotein cholesterol by statin prevents progression of coronary restenosis after successful stenting in acute myocardial infarction","volume":"45","author":"Iwata","year":"2006","journal-title":"Intern Med"},{"key":"R6-6-20210204","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/S0735-1097(01)01662-X","article-title":"Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation","volume":"38","author":"Walter","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R7-6-20210204","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1253\/circj.69.636","article-title":"Effect of pravastatin on progression of coronary atherosclerosis in patients after coronary artery bypass surgery","volume":"69","author":"Makuuchi","year":"2005","journal-title":"Circ J"},{"key":"R8-6-20210204","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11886-003-0105-1","article-title":"The J-curve in hypertension","volume":"5","author":"Cruickshank","year":"2003","journal-title":"Curr Cardiol Rep"},{"key":"R9-6-20210204","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archinte.163.3.361","article-title":"Validity of the JNC VI recommendations for the management of hypertension in a general population of Japanese elderly: the Hisayama study","volume":"163","author":"Arima","year":"2003","journal-title":"Arch Intern Med"},{"key":"R10-6-20210204","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7326\/0003-4819-144-12-200606200-00005","article-title":"Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?","volume":"144","author":"Messerli","year":"2006","journal-title":"Ann Intern Med"},{"key":"R11-6-20210204","first-page":"952","article-title":"The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004)","volume":"63","author":"Saruta","year":"2005","journal-title":"Nippon Rinsho"},{"key":"R12-6-20210204","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"key":"R13-6-20210204","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/01.CIR.0000156334.24955.B2","article-title":"Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial","volume":"111","author":"Fajadet","year":"2005","journal-title":"Circulation"},{"key":"R14-6-20210204","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1161\/01.CIR.0000127110.49192.72","article-title":"One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial","volume":"109","author":"Stone","year":"2004","journal-title":"Circulation"},{"key":"R15-6-20210204","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.jacc.2005.02.086","article-title":"Late angiographic stent thrombosis (LAST) events with drug-eluting stents","volume":"45","author":"Ong","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R16-6-20210204","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/0046-8177(93)90166-E","article-title":"Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody","volume":"24","author":"Takeya","year":"1993","journal-title":"Hum Pathol"},{"key":"R17-6-20210204","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/01.RES.84.3.306","article-title":"Anti-monocyte chemoattractant protein-1\/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries","volume":"84","author":"Furukawa","year":"1999","journal-title":"Circ Res"},{"key":"R18-6-20210204","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/01.RES.0000020561.03244.7E","article-title":"Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys","volume":"90","author":"Egashira","year":"2002","journal-title":"Circ Res"},{"key":"R19-6-20210204","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2169\/internalmedicine.47.0315","article-title":"Changes in CCR2 chemokine receptor expression and plasma MCP-1 concentration after the implantation of bare metal stents versus sirolimus-eluting stents in patients with stable angina","volume":"47","author":"Sako","year":"2008","journal-title":"Intern Med"},{"key":"R20-6-20210204","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2215\/CJN.04371206","article-title":"Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study","volume":"2","author":"Shepherd","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R21-6-20210204","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.HYP.0000136395.06810.cf","article-title":"Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress","volume":"44","author":"Zhou","year":"2004","journal-title":"Hypertension"},{"key":"R22-6-20210204","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ahj.2004.10.032","article-title":"Simvastatin does not inhibit intimal hyperplasia and restenosis but promotes plaque regression in normocholesterolemic patients undergoing coronary stenting: a randomized study with intravascular ultrasound","volume":"149","author":"Petronio","year":"2005","journal-title":"Am Heart J"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0b013e32832c4538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:50:41Z","timestamp":1786038641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00019501-200906000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0b013e32832c4538","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}